Areli Romero-López
Research Subjects
Areli Romero-López has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Melchor-López
Hospital General de Zona No. 8 y UMF “Dr. Gilberto Flores Izquierdo”, Instituto Mexicano del Seguro Social, Rio Magdalena 289, Col. Tizapan San Ángel, Alcaldía Álvaro Obregón, Mexico City 01090, Mexico
1 shared publication - Alejandro Hernández-Patricio
Laboratorio de Metabolismo Experimental e Investigación Clínica, CMN “20 de Noviembre”, ISSSTE, San Lorenzo 502, Colonia del Valle Sur, Benito Juárez, Mexico City 03104, Mexico
1 shared publication - Andrea Ramírez-Coyotecatl
Laboratorio de Metabolismo Experimental e Investigación Clínica, CMN “20 de Noviembre”, ISSSTE, San Lorenzo 502, Colonia del Valle Sur, Benito Juárez, Mexico City 03104, Mexico
1 shared publication - Christian Alejandro Delaflor-Wagner
Institute for Social Security and Services for State Workers, Mexico City, Mexico
1 shared publication - Christian Gabriel Toledo-Lozano
Laboratorio de Metabolismo Experimental e Investigación Clínica, CMN “20 de Noviembre”, ISSSTE, San Lorenzo 502, Colonia del Valle Sur, Benito Juárez, Mexico City 03104, Mexico
1 shared publication - Deyanhira Palacios-Colunga
Facultad de Enfermería y Nutrición, Universidad Autónoma de San Luis Potosí, San Luis Potosí 78240, México
1 shared publication
Latest Publications
- Open Access
Association of Sarcopenia with Lower Adiponectin Levels and Reduced Estimated Appendicular Lean Mass in Patients with Metabolic Syndrome: A Cross-Sectional Study
Background: Sarcopenia is a progressive muscle disorder associated with metabolic syndrome (MS), in which early impairments in muscle strength and quality precede muscle mass loss. Simple, non-invasive measures such as handgrip strength, estimated appendicular skeletal muscle mass (eASM), and phase angle (PA) may aid early detection, while adipokines link muscle dysfunction to metabolic regulation. Objective: In the present study, we aimed to evaluate the association between sarcopenia markers and PA in patients with MS. Methods: A cross-sectional study was conducted in patients with MS, at a third-level hospital in Mexico City. Sarcopenia was assessed by handgrip strength and eASM; body composition and PA were measured using bioelectrical impedance; and plasma adipokines were quantified by ELISA. Results: Seventy-four (mean age, 57.7 years; 75% female; BMI, 32.5 kg/m2) participants with MS were included. Handgrip strength correlated with eASM (r = 0.64; p < 0.01) and PA (rho = 0.43; p < 0.01), and eASM also correlated with PA (rho = 0.40; p < 0.01) and predicted higher PA values (OR = 2.74; p = 0.042). The sarcopenic subgroup had lower brachial circumference and plasma adiponectin. Conclusions: Sarcopenia is frequent in MS and associated with lower adiponectin, suggesting a vulnerable condition. Functional/structural markers of sarcopenia showed significant correlation with PA, whereas combined methods may enhance the early detection and management of muscle deterioration in metabolic disease.
Open AccessAssociation of Sarcopenia with Lower Adiponectin Levels and Reduced Estimated Appendicular Lean Mass in Patients with Metabolic Syndrome: A Cross-Sectional Study
Background: Sarcopenia is a progressive muscle disorder associated with metabolic syndrome (MS), in which early impairments in muscle strength and quality precede muscle mass loss. Simple, non-invasive measures such as handgrip strength, estimated appendicular skeletal muscle mass (eASM), and phase angle (PA) may aid early detection, while adipokines link muscle dysfunction to metabolic regulation. Objective: In the present study, we aimed to evaluate the association between sarcopenia markers and PA in patients with MS. Methods: A cross-sectional study was conducted in patients with MS, at a third-level hospital in Mexico City. Sarcopenia was assessed by handgrip strength and eASM; body composition and PA were measured using bioelectrical impedance; and plasma adipokines were quantified by ELISA. Results: Seventy-four (mean age, 57.7 years; 75% female; BMI, 32.5 kg/m2) participants with MS were included. Handgrip strength correlated with eASM (r = 0.64; p < 0.01) and PA (rho = 0.43; p < 0.01), and eASM also correlated with PA (rho = 0.40; p < 0.01) and predicted higher PA values (OR = 2.74; p = 0.042). The sarcopenic subgroup had lower brachial circumference and plasma adiponectin. Conclusions: Sarcopenia is frequent in MS and associated with lower adiponectin, suggesting a vulnerable condition. Functional/structural markers of sarcopenia showed significant correlation with PA, whereas combined methods may enhance the early detection and management of muscle deterioration in metabolic disease.